BioCentury
ARTICLE | Company News

ImmunoGen deal

August 1, 1994 7:00 AM UTC

IMGN's Apoptosis Technology Inc. subsidiary entered into a three-year agreement with the Imperial Cancer Research Fund (U.K.) to develop compounds to regulate the growth or death of cells. Apoptosis T...